In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Egalet Corp.

www.egalet.com

Latest From Egalet Corp.

Opioid Sponsors Enter 2019 At A Crossroads

Recent regulatory trends at US FDA offer no clear path to success for sponsors developing opioids. As 2018 concludes with only one approval and at least five rejections, firms will need new strategies if they hope to bring the analgesics to market. 
Research & Development Neurology

Abuse-Deterrent Opioids: Where Are They Now?

The potential blockbuster category for abuse-deterrent opioids has fizzled. A few stalwarts are pushing on, but the return on investment for many drug manufacturers has been disappointing. Scrip tracked how opioids approved in the last eight years have performed.

Market Access Pricing Strategies

KemPharm And The Curious Case Of Launching A Brand Opioid Like A Generic

KemPharm is looking to sign a generic drug partner to launch its new brand opioid Apadaz, which says a lot about how the commercial promise of abuse-deterrent opioids has so far failed to materialize. 

Launches Generic Drugs

KemPharm And The Curious Case Of Launching A Brand Opioid Like A Generic

KemPharm is looking to sign a generic drug partner to launch its new brand opioid Apadaz, which says a lot about how the commercial promise of abuse-deterrent opioids has so far failed to materialize. 

Launches Generic Drugs
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Nasal
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Egalet AS
  • Egalet Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Egalet Corp.
  • Senior Management
  • Bob Radie, Pres. & CEO
    Stan Musial, CFO
    Patrick Shea, Chief Commercial Officer
    Mark Strobeck , PhD, EVP & COO
    Karsten Lindhardt, MSc, PhD, CSO
  • Contact Info
  • Egalet Corp.
    Phone: (45)(610) 833-4200
    600 Lee Rd.
    Ste. 100
    Wayne, PA 19087
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register